262 related articles for article (PubMed ID: 29791895)
21. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26422096
[TBL] [Abstract][Full Text] [Related]
22. Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S31-6. PubMed ID: 26121348
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26422094
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and Acid-suppressive Effects of Esomeprazole in Infants 1-24 Months Old With Symptoms of Gastroesophageal Reflux Disease.
Omari T; Davidson G; Bondarov P; Nauclér E; Nilsson C; Lundborg P
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S2-8. PubMed ID: 26121346
[TBL] [Abstract][Full Text] [Related]
25. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease.
Liang CM; Kuo MT; Hsu PI; Kuo CH; Tai WC; Yang SC; Wu KL; Wang HM; Yao CC; Tsai CE; Wang YK; Wang JW; Huang CF; Wu DC; Chuah SK;
World J Gastroenterol; 2017 Dec; 23(47):8395-8404. PubMed ID: 29307999
[TBL] [Abstract][Full Text] [Related]
26. Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial.
Lundell L; Hatlebakk J; Galmiche JP; Attwood SE; Ell C; Fiocca R; Persson T; Nagy P; Eklund S; Lind T
Curr Med Res Opin; 2015 Jan; 31(1):65-73. PubMed ID: 25350223
[TBL] [Abstract][Full Text] [Related]
27. Safety and Tolerability of Esomeprazole in Children With Gastroesophageal Reflux Disease.
Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S16-23. PubMed ID: 26121345
[TBL] [Abstract][Full Text] [Related]
28. Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response.
Earp JC; Mehrotra N; Peters KE; Fiorentino RP; Griebel D; Lee SC; Mulberg A; Röhss K; Sandström M; Taylor A; Tornøe CW; Wynn EL; Van der Walt JS; Garnett C
J Pediatr Gastroenterol Nutr; 2017 Sep; 65(3):272-277. PubMed ID: 27875488
[TBL] [Abstract][Full Text] [Related]
29. Rapid resolution of sleep disturbances related to frequent reflux: effect of esomeprazole 20 mg in two randomized, double-blind, controlled trials.
Johnson DA; Le Moigne A; Hugo V; Nagy P
Curr Med Res Opin; 2015 Feb; 31(2):243-50. PubMed ID: 25478944
[TBL] [Abstract][Full Text] [Related]
30. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
Franke A; Hepp C; Harder H; Beglinger C; Singer MV
Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
[TBL] [Abstract][Full Text] [Related]
31. The impact of intensifying acid suppression on sleep disturbance related to gastro-oesophageal reflux disease in primary care.
Moayyedi P; Hunt R; Armstrong D; Lei Y; Bukoski M; White R
Aliment Pharmacol Ther; 2013 Apr; 37(7):730-7. PubMed ID: 23432146
[TBL] [Abstract][Full Text] [Related]
32. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.
Kulig M; Leodolter A; Vieth M; Schulte E; Jaspersen D; Labenz J; Lind T; Meyer-Sabellek W; Malfertheiner P; Stolte M; Willich SN
Aliment Pharmacol Ther; 2003 Oct; 18(8):767-76. PubMed ID: 14535869
[TBL] [Abstract][Full Text] [Related]
33. On-demand versus half-dose continuous therapy with esomeprazole for maintenance treatment of gastroesophageal reflux disease: A randomized comparative study.
Cho JH; Koo JY; Kim KO; Lee SH; Jang BI; Kim TN
Medicine (Baltimore); 2018 Oct; 97(43):e12732. PubMed ID: 30412065
[TBL] [Abstract][Full Text] [Related]
34. Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia.
Fock KM; Teo EK; Ang TL; Chua TS; Ng TM; Tan YL
World J Gastroenterol; 2005 May; 11(20):3091-8. PubMed ID: 15918196
[TBL] [Abstract][Full Text] [Related]
35. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
Kiljander TO; Junghard O; Beckman O; Lind T
Am J Respir Crit Care Med; 2010 May; 181(10):1042-8. PubMed ID: 20110554
[TBL] [Abstract][Full Text] [Related]
36. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.
Galmiche JP; Hatlebakk J; Attwood S; Ell C; Fiocca R; Eklund S; Långström G; Lind T; Lundell L;
JAMA; 2011 May; 305(19):1969-77. PubMed ID: 21586712
[TBL] [Abstract][Full Text] [Related]
37. The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.
Jha LK; Maradey-Romero C; Gadam R; Hershcovici T; Fass OZ; Quan SF; Guillen J; Fass R
Neurogastroenterol Motil; 2015 Feb; 27(2):237-45. PubMed ID: 25484104
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Rabeprazole and Other Proton Pump Inhibitors in Managing GERD with Varying Severity: A Retrospective, Real-world EMR-based Study (POWER GERD Study).
Lawate P; Jilawar N; Vyas K; Pebbili KK; Desai S; Rathod R; Kotak B; Paspulate A
J Assoc Physicians India; 2023 Oct; 71(10):37-44. PubMed ID: 38716522
[No Abstract] [Full Text] [Related]
39. Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.
Steingoetter A; Sauter M; Curcic J; Liu D; Menne D; Fried M; Fox M; Schwizer W
BMC Gastroenterol; 2015 Sep; 15():111. PubMed ID: 26328588
[TBL] [Abstract][Full Text] [Related]
40. Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease.
Bayerdörffer E; Bigard MA; Weiss W; Mearin F; Rodrigo L; Dominguez Muñoz JE; Grundling H; Persson T; Svedberg LE; Keeling N; Eklund S
BMC Gastroenterol; 2016 Apr; 16():48. PubMed ID: 27080034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
